DePuy Synthes names CFO ahead of J&J split

Category: Markets

Published: 2026-06-30T15:13:02.000Z

DePuy Synthes, Johnson & Johnson's orthopedics business, has appointed Christina Zamarro as its new CFO in anticipation of its planned separation from J&J. Zamarro, who previously served as CFO at Goodyear Tire & Rubber Company, brings extensive experience in managing global transformation programs. This appointment fills a crucial leadership role as J&J progresses with the spin-out, which is expected to be completed within 18 to 24 months of its initial October announcement.

Read the original source

News summary curated and translated by CausifyMarket. Always consult original sources before making any financial decision.